vs

Side-by-side financial comparison of BayCom Corp (BCML) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $25.9M, roughly 1.6× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -17.2%, a 43.7% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BCML vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.6× larger
STIM
$41.8M
$25.9M
BCML
Growing faster (revenue YoY)
STIM
STIM
+76.3% gap
STIM
85.7%
9.4%
BCML
Higher net margin
BCML
BCML
43.7% more per $
BCML
26.5%
-17.2%
STIM
More free cash flow
BCML
BCML
$29.4M more FCF
BCML
$30.1M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
STIM
STIM
Revenue
$25.9M
$41.8M
Net Profit
$6.9M
$-7.2M
Gross Margin
52.0%
Operating Margin
36.6%
-12.1%
Net Margin
26.5%
-17.2%
Revenue YoY
9.4%
85.7%
Net Profit YoY
12.1%
43.2%
EPS (diluted)
$0.63
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
STIM
STIM
Q4 25
$25.9M
$41.8M
Q3 25
$25.7M
$37.3M
Q2 25
$24.7M
$38.1M
Q1 25
$24.3M
$32.0M
Q4 24
$23.7M
$22.5M
Q3 24
$25.6M
$18.5M
Q2 24
$23.8M
$16.4M
Q1 24
$24.5M
$17.4M
Net Profit
BCML
BCML
STIM
STIM
Q4 25
$6.9M
$-7.2M
Q3 25
$5.0M
$-9.0M
Q2 25
$6.4M
$-10.1M
Q1 25
$5.7M
$-12.7M
Q4 24
$6.1M
$-12.7M
Q3 24
$6.0M
$-13.3M
Q2 24
$5.6M
$-9.8M
Q1 24
$5.9M
$-7.9M
Gross Margin
BCML
BCML
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
BCML
BCML
STIM
STIM
Q4 25
36.6%
-12.1%
Q3 25
26.3%
-19.6%
Q2 25
35.3%
-21.1%
Q1 25
31.6%
-34.4%
Q4 24
34.2%
-51.0%
Q3 24
32.4%
-41.7%
Q2 24
31.9%
-51.7%
Q1 24
33.3%
-39.4%
Net Margin
BCML
BCML
STIM
STIM
Q4 25
26.5%
-17.2%
Q3 25
19.5%
-24.3%
Q2 25
25.8%
-26.6%
Q1 25
23.4%
-39.6%
Q4 24
25.9%
-56.4%
Q3 24
23.5%
-72.0%
Q2 24
23.6%
-59.8%
Q1 24
24.0%
-45.2%
EPS (diluted)
BCML
BCML
STIM
STIM
Q4 25
$0.63
$-0.10
Q3 25
$0.46
$-0.13
Q2 25
$0.58
$-0.15
Q1 25
$0.51
$-0.21
Q4 24
$0.55
$-0.34
Q3 24
$0.54
$-0.44
Q2 24
$0.50
$-0.33
Q1 24
$0.51
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$338.6M
$22.4M
Total Assets
$2.6B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
STIM
STIM
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Q1 24
$47.7M
Total Debt
BCML
BCML
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
BCML
BCML
STIM
STIM
Q4 25
$338.6M
$22.4M
Q3 25
$334.3M
$27.4M
Q2 25
$330.6M
$27.1M
Q1 25
$329.3M
$35.5M
Q4 24
$324.4M
$27.7M
Q3 24
$321.7M
$9.4M
Q2 24
$315.3M
$19.4M
Q1 24
$314.2M
$27.7M
Total Assets
BCML
BCML
STIM
STIM
Q4 25
$2.6B
$141.6M
Q3 25
$2.6B
$145.5M
Q2 25
$2.6B
$134.7M
Q1 25
$2.6B
$142.0M
Q4 24
$2.7B
$140.9M
Q3 24
$2.6B
Q2 24
$2.6B
$96.8M
Q1 24
$2.6B
$103.8M
Debt / Equity
BCML
BCML
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
STIM
STIM
Operating Cash FlowLast quarter
$31.8M
$908.0K
Free Cash FlowOCF − Capex
$30.1M
$692.0K
FCF MarginFCF / Revenue
116.2%
1.7%
Capex IntensityCapex / Revenue
6.7%
0.5%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
STIM
STIM
Q4 25
$31.8M
$908.0K
Q3 25
$7.3M
$-785.0K
Q2 25
$6.4M
$-3.5M
Q1 25
$9.3M
$-17.0M
Q4 24
$30.4M
$-8.6M
Q3 24
$9.6M
$-5.4M
Q2 24
$7.7M
$-5.0M
Q1 24
$5.1M
$-12.0M
Free Cash Flow
BCML
BCML
STIM
STIM
Q4 25
$30.1M
$692.0K
Q3 25
$6.2M
$-899.0K
Q2 25
$5.6M
$-3.8M
Q1 25
$9.1M
$-17.2M
Q4 24
$28.7M
$-8.7M
Q3 24
$9.4M
$-5.8M
Q2 24
$7.4M
$-5.6M
Q1 24
$3.9M
$-12.4M
FCF Margin
BCML
BCML
STIM
STIM
Q4 25
116.2%
1.7%
Q3 25
24.3%
-2.4%
Q2 25
22.8%
-9.9%
Q1 25
37.6%
-53.8%
Q4 24
121.1%
-38.6%
Q3 24
36.6%
-31.3%
Q2 24
31.2%
-34.0%
Q1 24
16.1%
-71.1%
Capex Intensity
BCML
BCML
STIM
STIM
Q4 25
6.7%
0.5%
Q3 25
4.3%
0.3%
Q2 25
3.0%
0.7%
Q1 25
0.6%
0.7%
Q4 24
7.2%
0.4%
Q3 24
1.0%
2.1%
Q2 24
1.0%
3.7%
Q1 24
4.7%
2.2%
Cash Conversion
BCML
BCML
STIM
STIM
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons